Hints and tips:
...This was the moment that led to the whole world getting neckache and ushered generations into surgical attachment to their phones....
...Smith & Nephew has held talks to buy NuVasive, a maker of medical instruments used in spinal surgery, in a deal that would be worth more than $3bn and mark the largest acquisition by the British medical...
...Mr Nawana takes over as Smith & Nephew is facing pressure from activist investor Elliott Advisors, which has been pressing for divestments....
...Stryker, another US device maker, last month confirmed it had been evaluating a bid for Smith & Nephew, its UK-based rival, but had decided against it – at least for now....
...The press release: In response to market speculation, Synthes, Inc....
...J&J earlier this year made an unsuccessful bid for Smith & Nephew, the UK hip and knee replacement company that was said to be valued at nearly $11bn....
...Hints of increased competition concerns held back Smith & Nephew, unchanged at 467p....
...The consortium outbid several other buyers, including Smith & Nephew, which was also beaten by Zimmer in the race to buy Switzerland’s Centerpulse in 2003....
...Potential bidders could include Smith & Nephew, Johnson & Johnson, Stryker and Zimmer, all of which have a significant presence in the wound care sector....
...US prosecutors subpoenaed three US companies and Britain’s Smith Nephew as part of an investigation into how implant makers market their products to surgeons....
...Meanwhile, I earmarked cash should either Zimmer or Smith & Nephew become cheaper. For months, nothing happened....
...Synthes, the Swiss surgical devices manufacturer, suffered as rival Smith Nephew launched a new system to treat fractures which will compete head on with a Synthes product....
International Edition